{
    "pmcid": "9356539",
    "qa_pairs": {
        "How does the RIVIA assay measure the degree of inhibition of spike protein binding to ACE2?": [
            "Via chemiluminescence.",
            "Using fluorescence resonance energy transfer (FRET).",
            "By measuring changes in electrical impedance.",
            "Through colorimetric detection."
        ],
        "What characteristic of nanobodies allows them to access epitopes less accessible to conventional antibodies?": [
            "Their small size and unique structure.",
            "Their ability to form multivalent complexes.",
            "Their higher affinity for viral proteins.",
            "Their longer half-life in circulation."
        ],
        "What is the primary advantage of the RIVIA assay over traditional virus neutralization tests (VNTs) and pseudovirus neutralization assays (pVNAs)?": [
            "RIVIA can be completed in less than 1.5 hours without the need for BSL-2 or BSL-3 facilities.",
            "RIVIA requires fewer reagents and is less expensive to perform.",
            "RIVIA provides more detailed structural information about antibody binding.",
            "RIVIA can detect a wider range of viral variants than traditional assays."
        ],
        "Which SARS-CoV-2 variant did Nb21 lose activity against, according to the study?": [
            "Beta variant.",
            "Alpha variant.",
            "Gamma variant.",
            "Delta variant."
        ],
        "Which nanobodies demonstrated strong neutralizing activity with low IC50 values in the study?": [
            "Nb21 and mNb6.",
            "Nb15 and mNb3.",
            "Nb10 and mNb8.",
            "Nb25 and mNb12."
        ]
    }
}